International Vaccine Access Center
One Dose at a Time: Mobilizing to Eliminate Cervical Cancer in Nigeria
Nigeria introduced the single-dose HPV vaccine into its routine immunization program in October 2023.
Watch "Ask the Experts: Why Measles Rates Are on the Rise"
Watch our latest webinar for an overview of the current state of measles in the U.S. and around the world.
The 2023 Pneumonia and Diarrhea Progress Report is out
The latest annual report tracks progress against leading infectious killers of children across 15 key countries.
Accelerating global access to life-saving vaccines.
We apply rigorous science to build knowledge and support for the value of vaccines.
The International Vaccine Access Center accelerates equitable and sustainable access to vaccines in low- and middle-income countries by generating, synthesizing, and using evidence to inform decision making and action.
Where We Work
IVAC works with governments and major research institutions in 38 countries. Learn more about us.
What We Do: Project Highlights
Vaccine Information and Epidemiology Window (VIEW-HUB)
VIEW-hub is IVAC’s publicly accessible interactive platform to visualize real-time information on vaccine use, product type, coverage levels, impact assessments, and disease burden estimates. It can be utilized to track progress and strategize ways to accelerate and optimize vaccine implementation.
Vaccine Economics Research for Sustainability & Equity (VERSE)
VERSE will compute the economic benefits and return-on-investment of vaccines, create a standardized model for assessing, tracking, and targeting vaccine coverage inequity at the country level and for monetizing the economic losses due to inequity, and more.
READ MORE >
Sign up for our monthly newsletter to receive the latest updates on immunization-related science, policy, and access from the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health.